Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Nicotine Polacrilex Patent Expiration

Nicotine Polacrilex was first introduced by Haleon Us Holdings Llc in its drug Nicorette on Feb 9, 1996. Another drug containing Nicotine Polacrilex is Nicorette (Mint). 13 different companies have introduced drugs containing Nicotine Polacrilex.


Nicotine Polacrilex Patents

Given below is the list of patents protecting Nicotine Polacrilex, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nicorette US8501164 Nicotine lozenge compositions Jun 14, 2029 Haleon Us Holdings
Nicorette US8940772 Nicotine lozenge composition Apr 30, 2029 Haleon Us Holdings
Nicorette US8323683 Flavoring of drug-containing chewing gums Apr 30, 2028 Haleon Us Holdings



Nicotine Polacrilex's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Nicotine Polacrilex Generic API Manufacturers

Several generic applications have been filed for Nicotine Polacrilex. The first generic version for Nicotine Polacrilex was by P And L Development Llc and was approved on Mar 15, 1999. And the latest generic version is by Dr Reddys Laboratories Sa and was approved on Jul 17, 2025.

Given below is the list of companies who have filed for Nicotine Polacrilex generic, along with the locations of their manufacturing plants worldwide.